Gilead Sciences, Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
8.1
Buy
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
GILD
High-quality business with 41% return on equity and 29% profit margins.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
BUY
Target $158.36 (+20.0%)
28 analysts
BUY
Target $252.42 (+9.9%)
24 analysts
Fundamentals
GILD
JNJ
19.5×
Trailing P/E
26.6×
13.7×
Forward P/E
18.1×
28.9%
Profit Margin
21.8%
78.8%
Gross Margin
68.0%
40.7%
ROE
26.4%
4.7%
Revenue Growth
9.9%
23.4%
Earnings Growth
-52.9%
0.40
Beta
0.33
—
Price / Book
—
$163.8B
Market Cap
$553.1B
$95 – $157
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.